Table 1:

Pre-implant characteristics of the sample

Characteristic (mean ± SD or n (%))	Sample (n=101)
Patient age (in years)	53.1 ± 13.9
Female	20 (19.8%)
Caucasian	83 (82.2%)
Body Mass Index (kg/m2)	28.9 ± 5.4
Ischemic Etiology	34 (33.7%)
Comorbidities:
Type II Diabetes Mellitus	41 (40.6%)
Sleep Apnea/Sleep Disordered Breathing	46 (45.5%)
Hypertension	52 (51.5%)
Pulmonary Hypertension	34 (33.7%)
Atrial Fibrillation	49 (48.5%)
Chronic Kidney Disease Stage 3	37 (36.6%)
Chronic Obstructive Pulmonary Disease	22 (21.8%)
Ne York Heart Association Class III/IV	97 (96.0%)
Center Ventricular Ejection Fraction (%)	20.5 ± 2.8
Center Ventricular Internal Diastolic Diameter (cm)	7.4 ± 1.1
Pulmonary Capillary edge Pressure (mm Hg)	23.4 ± 8.6
Right Atrial Pressure (mm Hg)	9.3 ± 4.8
Cardiac Index (by Fick Equation) (L/min/m2)	1.9 ± 0.5
V02 max (L/min)	15.0 ± 4.5
Serum Sodium (mEq/L)	134.4 ± 4.1
Serum Hemoglobin (%)	12.1 ± 2.0
Blood Urea Nitrogen/Creatinine Ratio	22.5 ± 8.3
Continuous Inotropic Support	72 (71.3%)
Intra-Aortic Balloon Pump	43 (42.6%)
Bridge to Transplant	68 (67.3%)